首页> 美国卫生研究院文献>Journal of Cellular and Molecular Medicine >A transcriptomic study for identifying cardia‐ and non–cardia‐specific gastric cancer prognostic factors using genetic algorithm‐based methods
【2h】

A transcriptomic study for identifying cardia‐ and non–cardia‐specific gastric cancer prognostic factors using genetic algorithm‐based methods

机译:使用基于遗传算法的方法鉴定贲门和非贲门和非贲门癌胃癌预后因子的转录组研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gastric cancer (GC) is a heterogeneous tumour with numerous differences of epidemiologic and clinicopathologic features between cardia cancer and non‐cardia cancer. However, few studies were performed to construct site‐specific GC prognostic models. In this study, we identified site‐specific GC transcriptomic prognostic biomarkers using genetic algorithm (GA)‐based support vector machine (GA‐SVM) and GA‐based Cox regression method (GA‐Cox) in the Cancer Genome Atlas (TCGA) database. The area under time‐dependent receive operating characteristic (ROC) curve (AUC) regarding 5‐year survival and concordance index (C‐index) was used to evaluate the predictive ability of Cox regression models. Finally, we identified 10 and 13 prognostic biomarkers for cardia cancer and non‐cardia cancer, respectively. Compared to traditional models, the addition of these site‐specific biomarkers could notably improve the model preference (cardia: AUC vs AUC  = 0.720 vs 0.899,  = 8.75E‐08; non‐cardia: AUC vs AUC  = 0.798 vs 0.994,  = 7.11E‐16). The combined nomograms exhibited superior performance in cardia and non‐cardia GC survival prediction (C‐index  = 0.816; C‐index  = 0.812). We also constructed a user‐friendly GC site‐specific molecular system (GC‐SMS, ), which is freely available for users. In conclusion, we developed site‐specific GC prognostic models for predicting cardia cancer and non‐cardia cancer survival, providing more support for the individualized therapy of GC patients.
机译:胃癌(GC)是一种异质肿瘤,贲门癌和非贲门癌之间的流行病学和临床病理特征的许多差异。然而,对构建位点特异性GC预后模型进行了很少的研究。在本研究中,我们使用癌症基因组Atlas(TCGA)数据库(TCGA)数据库中的基于遗传算法(GA)支持向量机(GA-SVM)和GA-COX回归方法(GA-COX)(GA-COX)鉴定特异性GC转录组预后生物标志物。用于5年生存和一致性指数(C-Index)的时间依赖性接受经营特征(ROC)曲线(AUC)的区域用于评估COX回归模型的预测能力。最后,我们分别鉴定了10和13例贲门癌和非贲门癌的预后生物标志物。与传统模型相比,添加这些场地特定的生物标志物可以尤利地改善模型偏好(Cardia:AUC VS AUC = 0.720 Vs 0.899,= 8.75E-08;非Cardia:AUC VS AUC = 0.798 VS 0.994,= 7.11 E-16)。合并的载体图表在贲门和非贲门GC生存预测中表现出优异的性能(C-Index = 0.816; C-Index = 0.812)。我们还构建了一个用户友好的GC位点特定的分子系统(GC-SMS),可为用户自由使用。总之,我们开发了针对预测贲门癌和非贲门癌生存的现场特异性GC预后模型,为GC患者的个体化治疗提供了更多的支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号